{"entity":{"id":"da-bn-subtype-misclassification","kind":"bottleneck","name":"Wrong-subtype treatment","aka":[],"tldr":"Lewy body, vascular, and frontotemporal dementia are still treated as if they were typical Alzheimer’s disease, which can add harm.","summary":"Antipsychotics in Lewy body disease, antibodies without amyloid confirmation, and cholinesterase inhibitors pushed in FTD are examples of map failures, not just knowledge gaps.","asOf":"2026-09-21","links":[{"label":"NICE NG97","url":"https://www.nice.org.uk/guidance/ng97"}],"tags":["dementia-atlas"],"related":[],"cancers":["dementia-with-lewy-bodies","frontotemporal-dementia","vascular-dementia"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"stage":"biology","severity":"major","metrics":[],"causes":["Overlapping symptoms.","Limited access to specialist assessment.","Trial evidence dominated by Alzheimer’s disease."],"currentEfforts":["NICE NG97 pathway language.","Lewy body awareness materials."],"successLooksLike":"A medicine is offered only when the diagnosis and the label match, or the off-label use is explicit."},"route":"/bottlenecks/da-bn-subtype-misclassification/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"},{"id":"dementia","kind":"cancer","name":"Dementia (umbrella)","route":"/diagnoses/dementia/"},{"id":"dementia-with-lewy-bodies","kind":"cancer","name":"Dementia with Lewy bodies","route":"/diagnoses/dementia-with-lewy-bodies/"},{"id":"frontotemporal-dementia","kind":"cancer","name":"Frontotemporal dementia","route":"/diagnoses/frontotemporal-dementia/"},{"id":"mixed-dementia","kind":"cancer","name":"Mixed dementia","route":"/diagnoses/mixed-dementia/"},{"id":"vascular-dementia","kind":"cancer","name":"Vascular dementia","route":"/diagnoses/vascular-dementia/"}]}}